Objective: Recent scientific literature has widely described a possible major role of smell dysfunction as a specific symptom of coronavirus disease 2019. This systematic review may provide a more holistic approach to current knowledge of the disease. Methods: A systematic review was completed using Embase, PubMed and Web of Science databases that considered original articles focused on olfactory evaluation in coronavirus disease 2019 patients, published between March and May 2020, in English language. Results: From the 483 research papers initially identified, 32 original studies were selected, comprising a total of 17 306 subjects with a laboratory confirmed diagnosis of coronavirus disease 2019. Individual study sample sizes ranged from 6 to 6452 patients. This comprehensive analysis confirmed that olfactory disorders represent an important clinical feature in coronavirus disease 2019, with a prevalence of 11-100 per cent in included patients, although there was heterogeneity in terms of assessment tools and population selection criteria. Conclusion: The results indicate that an accurate clinical evaluation should be carried out using structured questionnaires and tests with olfactory substances.

Olfactory disorders in coronavirus disease 2019 patients: a systematic literature review / E. Fuccillo, A.M. Saibene, M.P. Canevini, G. Felisati. - In: JOURNAL OF LARYNGOLOGY AND OTOLOGY. - ISSN 0022-2151. - (2020). [Epub ahead of print] [10.1017/S0022215120002005]

Olfactory disorders in coronavirus disease 2019 patients: a systematic literature review

A.M. Saibene
Secondo
;
M.P. Canevini;G. Felisati
2020

Abstract

Objective: Recent scientific literature has widely described a possible major role of smell dysfunction as a specific symptom of coronavirus disease 2019. This systematic review may provide a more holistic approach to current knowledge of the disease. Methods: A systematic review was completed using Embase, PubMed and Web of Science databases that considered original articles focused on olfactory evaluation in coronavirus disease 2019 patients, published between March and May 2020, in English language. Results: From the 483 research papers initially identified, 32 original studies were selected, comprising a total of 17 306 subjects with a laboratory confirmed diagnosis of coronavirus disease 2019. Individual study sample sizes ranged from 6 to 6452 patients. This comprehensive analysis confirmed that olfactory disorders represent an important clinical feature in coronavirus disease 2019, with a prevalence of 11-100 per cent in included patients, although there was heterogeneity in terms of assessment tools and population selection criteria. Conclusion: The results indicate that an accurate clinical evaluation should be carried out using structured questionnaires and tests with olfactory substances.
COVID-19; SARS-CoV-2; Smell; Olfactory Nerve Diseases; Olfaction Disorders
Settore MED/31 - Otorinolaringoiatria
2020
15-set-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
olfactory disorder in COVID, SR (2020).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 233.73 kB
Formato Adobe PDF
233.73 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/769307
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
  • OpenAlex 19
social impact